Cargando…

Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides

A series of novel isatine-sulphonamide derivatives have been synthesized by combining isatin derivatives with sulphonamides. The structure of the synthesized compounds were elucidated by spectral analysis (IR, NMR and Mass). Investigation of anti-HIV activity was done against HIV-1(IIIB) in MT-4 cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvam, P., Murugesh, N., Chandramohan, M., Debyser, Z., Witvrouw, M.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040873/
https://www.ncbi.nlm.nih.gov/pubmed/21369440
http://dx.doi.org/10.4103/0250-474X.49121
_version_ 1782198388927758336
author Selvam, P.
Murugesh, N.
Chandramohan, M.
Debyser, Z.
Witvrouw, M.
author_facet Selvam, P.
Murugesh, N.
Chandramohan, M.
Debyser, Z.
Witvrouw, M.
author_sort Selvam, P.
collection PubMed
description A series of novel isatine-sulphonamide derivatives have been synthesized by combining isatin derivatives with sulphonamides. The structure of the synthesized compounds were elucidated by spectral analysis (IR, NMR and Mass). Investigation of anti-HIV activity was done against HIV-1(IIIB) in MT-4 cells and HIV integrase inhibitory activity. 4-(1-acetyl-5-methyl-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (SPIII-5ME-AC) inhibits the HIV Integrase enzymatic activity as both over all and strand transfer reaction and 4-(1-benzoyl-5-chloro-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzene sulfonamide (SPIII-5Cl-BZ) exhibits 36 percent maximum protection against HIV-1 at sub toxic concentration.
format Text
id pubmed-3040873
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30408732011-03-02 Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides Selvam, P. Murugesh, N. Chandramohan, M. Debyser, Z. Witvrouw, M. Indian J Pharm Sci Short Communication A series of novel isatine-sulphonamide derivatives have been synthesized by combining isatin derivatives with sulphonamides. The structure of the synthesized compounds were elucidated by spectral analysis (IR, NMR and Mass). Investigation of anti-HIV activity was done against HIV-1(IIIB) in MT-4 cells and HIV integrase inhibitory activity. 4-(1-acetyl-5-methyl-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (SPIII-5ME-AC) inhibits the HIV Integrase enzymatic activity as both over all and strand transfer reaction and 4-(1-benzoyl-5-chloro-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzene sulfonamide (SPIII-5Cl-BZ) exhibits 36 percent maximum protection against HIV-1 at sub toxic concentration. Medknow Publications 2008 /pmc/articles/PMC3040873/ /pubmed/21369440 http://dx.doi.org/10.4103/0250-474X.49121 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Selvam, P.
Murugesh, N.
Chandramohan, M.
Debyser, Z.
Witvrouw, M.
Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
title Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
title_full Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
title_fullStr Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
title_full_unstemmed Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
title_short Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
title_sort design, synthesis and antihiv activity of novel isatine-sulphonamides
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040873/
https://www.ncbi.nlm.nih.gov/pubmed/21369440
http://dx.doi.org/10.4103/0250-474X.49121
work_keys_str_mv AT selvamp designsynthesisandantihivactivityofnovelisatinesulphonamides
AT murugeshn designsynthesisandantihivactivityofnovelisatinesulphonamides
AT chandramohanm designsynthesisandantihivactivityofnovelisatinesulphonamides
AT debyserz designsynthesisandantihivactivityofnovelisatinesulphonamides
AT witvrouwm designsynthesisandantihivactivityofnovelisatinesulphonamides